SEROCONVERSION

作品数：35被引量：227H指数：9
导出分析报告
相关领域：医药卫生更多>>
相关作者：熊永红孔香兰杨德云更多>>
相关机构：新疆医科大学第五附属医院更多>>
相关期刊：《Cellular & Molecular Immunology》《Science China(Life Sciences)》《World Journal of Gastroenterology》《Journal of Health Science》更多>>
相关基金：国家自然科学基金广东省自然科学基金国家重点基础研究发展计划国家教育部博士点基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
选择条件：
  • 期刊=Science China（Life Sciences）x
共 条 记 录，以下是1-2
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?被引量：5
《Science China(Life Sciences)》2020年第12期1833-1849,共17页Ligong Lu Hui Zhang Meixiao Zhan Jun Jiang Hua Yin Danielle JDauphars Shi-You Li Yong Li You-Wen He 
supported by the National Key Research and Development Program of China(2017YFA0205200);the National Natural Science Foundation of China(81571785,81771957,81901857,81801811);Natural Science Foundation of Guangdong Province,China(2018A030313074)to Dr.Ligong Lu;the Zhuhai Municipal Science and Technology Foundation(ZH22046301200004PWC)to Dr.Shi-You Li;the Sunny Li Family fund to You-Wen He。
The newly emerged severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) has infected millions of people and caused tremendous morbidity and mortality worldwide. Effective treatment for coronavirus disease 2019(C...
关键词：COVID-19 SEROCONVERSION neutralizing antibody spike protein SARS-CoV-2 convalescent plasma VACCINE 
α-2-HS-glycoprotein is a potential marker predicting hepatitis B e antigen seroconversion in patients with chronic hepatitis B during treatment with pegylated interferon alfa-2b被引量：6
《Science China(Life Sciences)》2011年第1期39-47,共9页MA Hui WANG JiangHua GUO Fang WEI Lai 
supported by the National Basic Research Program of China (Grant Nos. 2005CB522902 and 2007CB512900);the National High Technology Research and Development Program of China (Grant No. 2006AA02A410);the National Natural Science Foundation of China (Grant No. 30901256);the Beijing Natural Science Foundation (Grant No. 7102153);National Science and Technology Major Project for Infectious Diseases Control During the 11th Five-Year Plan Period (Grant Nos. 2008ZX10002-012 and 2008ZX10002-013);Peking University People’s Hospital Research Development Funds (Grant No. RDC 2009-13);Key Clinical Research Program of Ministry of Health of China
The efficacy of interferon (IFN) is limited in about 1/3 of patients with chronic hepatitis B (CHB). We used two-dimensional electrophoresis (2-DE)-based proteomic strategies to identify potential serum markers predic...
关键词：α-2-HS-glycoprotein pegylated interferon alfa-2b chronic hepatitis B 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部